Paudel Robin, Dogra Prerna, Suman Saurav, Acharya Saurav, Matta Jyoti
Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
Department of Internal Medicine, Jersey City Medical Center, Jersey City, NJ, USA.
Case Rep Crit Care. 2016;2016:5232804. doi: 10.1155/2016/5232804. Epub 2016 Sep 8.
Amiodarone is an antiarrhythmic drug which is highly effective against a wide spectrum of ventricular tachyarrhythmias making it irreplaceable in certain group of patients. We report an unusual case of acute liver and renal failure within 24 hours of initiation of intravenous (IV) amiodarone which resolved after stopping the medication. The mechanism of acute liver and renal toxicity is not clearly known but is believed to be secondary to amiodarone induced (relative) hypotension, idiosyncratic reaction to the drug, and toxicity of the vector that carries the medication, polysorbate-80. In this case review, we discuss the hyperacute drug toxicity caused by IV amiodarone being a distinctly different entity compared to the adverse effects shown by oral amiodarone and support the suggestion that oral amiodarone can be safely administered even in patients who manifest acute hepatitis with the IV form.
胺碘酮是一种抗心律失常药物,对多种室性快速心律失常非常有效,在某些患者群体中具有不可替代的作用。我们报告了一例在静脉注射胺碘酮24小时内出现急性肝肾功能衰竭的罕见病例,停药后病情得到缓解。急性肝毒性和肾毒性的机制尚不清楚,但据信是继发于胺碘酮引起的(相对性)低血压、对该药物的特异反应以及携带药物的载体聚山梨酯80的毒性。在本病例回顾中,我们讨论了静脉注射胺碘酮引起的超急性药物毒性,它与口服胺碘酮所显示的不良反应明显不同,并支持即使在静脉注射胺碘酮出现急性肝炎的患者中也可安全给予口服胺碘酮的建议。